Molina Healthcare (MOH) Higher After Citi Lifts Price Target to $55
Tweet Send to a FriendGet Alerts MOH Hot Sheet
Price: $37.31 -0.51%
Rating Summary:
2 Buy, 8 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 24 | New: 24
Rating Summary:
2 Buy, 8 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 24 | New: 24
Trade MOH Now!
Molina Healthcare (NYSE: MOH) shares are up nearly 3 percent early after
Citi raised its price target from $36 to $55, while maintaining a Buy rating. The new price target represents 74% upside from Monday's close. The firm cited dual eligibility opportunity.
For an analyst ratings summary and ratings history on Molina Healthcare click here. For more ratings news on Molina Healthcare click here.
Shares of Molina Healthcare closed at $31.58 yesterday, with a 52 week range of $13.93-$43.43.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Citi raised its price target from $36 to $55, while maintaining a Buy rating. The new price target represents 74% upside from Monday's close. The firm cited dual eligibility opportunity.
For an analyst ratings summary and ratings history on Molina Healthcare click here. For more ratings news on Molina Healthcare click here.
Shares of Molina Healthcare closed at $31.58 yesterday, with a 52 week range of $13.93-$43.43.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: UBS Downgrades Carnival (CCL) to Neutral; Worst May Not Be Behind
- Goldman Sachs Downgrades Thoratec (THOR) to Neutral
- Actavis (ACT) Fairly Valued After Run-Up - Jefferies
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
CitiLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

